Treatment‐free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|2|305-308

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.2, 2015-01, pp. : 305-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment‐free remission

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 242-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 744-744

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

By  

Acta Haematologica, Vol. 135, Iss. 3, 2015-11 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Nilotinib after imatinib first‐line: a real‐life longitudinal cohort of patients with chronic myeloid leukaemia in chronic phase

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 356-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Retinoic Acid Treatment on Cytogenetic Remission of Chronic Myeloid Leukaemia

By  

Acta Haematologica, Vol. 109, Iss. 2, 2003-03 ,pp. : 84-89

Karger

Access to resources Recommend Favorite